Serum levels of campesterol and the ratio of campesterol to cholesterol have been proposed as measures of cardiac risk.
Although studies in humans have shown that consumption of phytosterols may reduce LDL levels, evidence to recommend them as a treatment for hypercholesterolemia is insufficient.